These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6617610)

  • 1. A study on cadmium-induced nephropathy in rats pretreated with puromycin aminonucleoside.
    Yamada YK; Shimizu F; Suzuki KT; Yamamura M; Kubota K
    Environ Res; 1983 Oct; 32(1):179-87. PubMed ID: 6617610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cadmium-induced hepatic and renal injury in chronically exposed rats: likely role of hepatic cadmium-metallothionein in nephrotoxicity.
    Dudley RE; Gammal LM; Klaassen CD
    Toxicol Appl Pharmacol; 1985 Mar; 77(3):414-26. PubMed ID: 3975909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Puromycin aminonucleoside nephropathy: ultrastructure, glomerular polyanion, and cell surface markers.
    Rossmann P; Bukovský A; Matousovic K; Holub M; Král J
    J Pathol; 1986 Apr; 148(4):337-48. PubMed ID: 3517267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.
    Hoyer JR; Mauer SM; Michael AF
    J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of glomerular localization of subepithelial immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and aminonucleoside of puromycin on passive Heymann nephritis in rats.
    Salant DJ; Belok S; Stilmant MM; Darby C; Couser WG
    Lab Invest; 1979 Jul; 41(1):89-99. PubMed ID: 376941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nephrotoxicity test on T-3262 in rats with experimental nephropathy].
    Nagai A; Nagasawa M; Ooyama S; Kaga H; Kitou N; Yoneda T
    Jpn J Antibiot; 1989 Apr; 42(4):817-30. PubMed ID: 2769936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.
    Liu J; Habeebu SS; Liu Y; Klaassen CD
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):48-58. PubMed ID: 9875299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy.
    Marinides GN; Groggel GC; Cohen AH; Border WA
    Kidney Int; 1990 Feb; 37(2):749-57. PubMed ID: 2407887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin.
    Klein DJ; Dehnel PJ; Oegema TR; Brown DM
    Lab Invest; 1984 May; 50(5):543-51. PubMed ID: 6232422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of protamine on proteinuria and glomerular sclerosis in aminonucleoside nephropathy.
    Saito T; Yamakage K; Kurosawa K; Kyogoku Y; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1982 Apr; 136(4):461-2. PubMed ID: 7101279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aminonucleoside, daunomycin, and adriamycin on carbon oxidation by glomeruli.
    Kaplan BS; Renaud L; Drummond KN
    Lab Invest; 1976 Feb; 34(2):174-8. PubMed ID: 1249918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic combined exposure to cadmium and arsenic exacerbates nephrotoxicity, particularly in metallothionein-I/II null mice.
    Liu J; Liu Y; Habeebu SM; Waalkes MP; Klaassen CD
    Toxicology; 2000 Jul; 147(3):157-66. PubMed ID: 10924798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of cadmium-metallothionein pretreatment on tolerance of rat kidney cortical cells to cadmium toxicity in vitro and in vivo.
    Jin T; Nordberg GF; Nordberg M
    Pharmacol Toxicol; 1987 May; 60(5):345-9. PubMed ID: 3615344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadmium nephrotoxicity and evacuation from the body in a rat modeled subchronic intoxication.
    Aoyagi T; Hayakawa K; Miyaji K; Ishikawa H; Hata M
    Int J Urol; 2003 Jun; 10(6):332-8. PubMed ID: 12757605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats.
    Olson JL; Rennke HG; Venkatachalam MA
    Lab Invest; 1981 Mar; 44(3):271-9. PubMed ID: 7464051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of puromycin aminonucleoside on HSPG core protein content of glomerular epithelial cells.
    Kasinath BS; Singh AK; Kanwar YS; Lewis EJ
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F590-6. PubMed ID: 2972214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the aminonucleoside of puromycin on glomerular epithelial cells in vitro.
    Fishman JA; Karnovsky MJ
    Am J Pathol; 1985 Mar; 118(3):398-407. PubMed ID: 3976843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats.
    Couser WG; Jermanovich NB; Belok S; Stilmant MM; Hoyer JR
    J Clin Invest; 1978 Mar; 61(3):561-72. PubMed ID: 147884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
    Garin EH; Boggs KP; Burke FC
    Int J Pediatr Nephrol; 1985; 6(2):117-20. PubMed ID: 4030221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DMSO potentiates aminonucleoside of puromycin nephrosis in rats.
    Spear GS; Nguyen D; Conklin S; Wikle JS; Fan J; Lan YH; Allen J; Reineck S
    J Pathol; 1987 Oct; 153(2):183-7. PubMed ID: 3694323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.